SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-006243
Filing Date
2024-05-14
Accepted
2024-05-14 16:26:39
Documents
58
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q endra_10q.htm   iXBRL 10-Q 555377
2 CERTIFICATION endra_ex311.htm EX-31.1 8947
3 CERTIFICATION endra_ex312.htm EX-31.2 11231
4 CERTIFICATION endra_ex321.htm EX-32.1 4242
  Complete submission text file 0001654954-24-006243.txt   3234289

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ndra-20240331.xsd EX-101.SCH 44725
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20240331_lab.xml EX-101.LAB 243863
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20240331_cal.xml EX-101.CAL 37542
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20240331_pre.xml EX-101.PRE 198556
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20240331_def.xml EX-101.DEF 112000
62 EXTRACTED XBRL INSTANCE DOCUMENT endra_10q_htm.xml XML 346253
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37969 | Film No.: 24944811
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)